Inspire Investing, LLC Revance Therapeutics, Inc. Transaction History

Inspire Investing, LLC

  • $858 Million
  • Q4 2024

A detailed history of Inspire Investing, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 131,892 shares of RVNC stock, worth $338,962. This represents 0.04% of its overall portfolio holdings.

Number of Shares
131,892
Previous 78,055 68.97%
Holding current value
$338,962
Previous $200,000 69.0%
% of portfolio
0.04%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
N/A
53,837 Added 68.97%
131,892 $338,000
Q3 2024

Oct 10, 2024
SELL
$2.57 - $2.57 $156,831 - $156,831
-61,024 Reduced 43.88%
78,055 $200,000
Q2 2024

Aug 12, 2024
BUY
$2.34 - $4.73 $154,250 - $311,796
65,919 Added 90.1%
139,079 $357,000
Q1 2024

May 07, 2024
BUY
$4.65 - $9.31 $137,849 - $275,994
29,645 Added 68.13%
73,160 $359,000
Q4 2023

Feb 12, 2024
BUY
$5.81 - $11.2 $98,322 - $189,537
16,923 Added 63.64%
43,515 $382,000
Q3 2023

Oct 26, 2023
BUY
$11.47 - $25.07 $162,311 - $354,765
14,151 Added 113.74%
26,592 $305,000
Q2 2023

Jul 31, 2023
BUY
$24.7 - $37.61 $98,231 - $149,574
3,977 Added 46.99%
12,441 $314,000
Q1 2023

Apr 24, 2023
SELL
$18.36 - $35.27 $79,572 - $152,860
-4,334 Reduced 33.86%
8,464 $272,000
Q4 2022

Jan 26, 2023
BUY
$18.32 - $30.66 $93,596 - $156,641
5,109 Added 66.45%
12,798 $0
Q3 2022

Nov 07, 2022
SELL
$14.33 - $28.47 $112,504 - $223,517
-7,851 Reduced 50.52%
7,689 $208,000
Q2 2022

Aug 10, 2022
BUY
$11.52 - $20.4 $38,200 - $67,646
3,316 Added 27.13%
15,540 $215,000
Q1 2022

Apr 21, 2022
SELL
$12.36 - $20.31 $39,341 - $64,646
-3,183 Reduced 20.66%
12,224 $238,000
Q4 2021

Feb 14, 2022
BUY
$12.46 - $27.87 $191,971 - $429,393
15,407 New
15,407 $251,000

Others Institutions Holding RVNC

# of Institutions
226
Shares Held
82.9M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email